
|Articles|October 30, 2006
AAIPharma Completes Acquisition of CAC and Launches New Business Unit
AAIPharma Completes CAC Acquisition
Advertisement
Wilmington, N.C., October 26, 2006--AAIPharma Inc. announced today that it has completed the previously announced acquisition of Cvitkovic & Associès Consultants S.A. (CAC), an international contract research organization specializing in oncology drug development and medical consulting. CAC has clinical operations in France, Croatia, Russia, Spain, Argentina, Peru, Australia, and the United States. As a result of the acquisition, CAC has become the foundation of AAIOncology, a global business unit dedicated to oncology drug development.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
2
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
3
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
4
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
5




